Fundraising Fox
/Companies
Sign in

ZebiAI Therapeutics

Chestnut Hill, US · Founded 2019 · Delaware corporation · 1 known investors

Find your way into ZebiAI Therapeutics

Founders & leadership

BC
Brant C. BinderNamed on SEC filing
PA
Philip AustinNamed on SEC filingManaging Partner and Co-Founder at Anterra Capital
RWRichard Wagner
Richard WagnerCEO and Founder2019–2021CEO, Cofounder at Bonitobio

Investors · 1

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2019

▶$10MraisedJan 2020 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Brant C. BinderExecutive Officer, Director
  • Philip AustinDirector
  • Richard WagnerDirector
Offering amount
$10M
Amount sold
$10M
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through ZebiAI Therapeutics went on to found or lead other companies.

Philip AustinDirectorFounded Enko Chem +1Richard WagnerDirectorFounded Bonito Biosciences

Frequently asked questions

Who are ZebiAI Therapeutics's investors?
ZebiAI Therapeutics's investors include Anterra Capital.
How much funding has ZebiAI Therapeutics raised?
ZebiAI Therapeutics has disclosed $10M raised across 1 round.
Where is ZebiAI Therapeutics headquartered?
ZebiAI Therapeutics is headquartered in Chestnut Hill, US.